Who Is Funding the Science That's Too Early for Venture Capital?
April 22, 2026
New York Genome Center
#25 in Institutes and Centers
25Institution Overview
Overall
Ranking
25
41
Rank in
Research Capabilities
34
Rank in
Entrepreneurial Readiness
11
Rank in
Market Translation
New York, NY
The New York Genome Center ranks 25th among the 60 biomedical institutes evaluated by the Cure Innovation Index. Located in New York, New York, the center's strongest standing is in market translation, where it places in the upper tier among peer institutions. Research capabilities and entrepreneurial readiness rank in the lower tier of the index. The center holds a Clinical and Translational Science Award, operates an incubator and accelerator, and conducts clinical trials through faculty principal investigators. Its mission centers on genomics research within one of the most concentrated biomedical research environments in the U.S.
Ranking Metrics
Research Capabilities
New York Genome Center ranked below average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, New York Genome Center fared best in Cutting Edge Science.
Learn MoreEntrepreneurial Readiness
New York Genome Center ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, New York Genome Center fared best in Faculty Engagement.
Learn MoreMarket Translation
New York Genome Center ranked below average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, New York Genome Center fared best in Industry Connections.
Learn More
Cure Innovation Index Methodology
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Insights From the Cure Innovation Index
Explore by Category
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.
